Vitrolife Q2: Reasuring progress - Redeye

Vitrolife continues to improve organic growth and margins with good balance support from all regions and both technology and consumables. We also point to the improved gross margins in Q2 over the earlier Q1, which is essential after a softer period.

Länk till analysen i sin helhet: https://www.redeye.se/research/848665/vitrolife-q2-reasuring-progress?utm_source=finwire&utm_medium=RSS